SINECOD

This brand name is authorized in Cyprus, Croatia, Malta, Poland, Romania, Turkey

Active ingredients

The drug SINECOD contains one active pharmaceutical ingredient (API):

1 Butamirate
UNII 67HP51L98R - BUTAMIRATE CITRATE

Butamirate (or brospamin) is a cough suppressant. It binds to the cough center in the medulla oblongata, more specifically the dextromethorphan-binding site in guinea pig brain with high affinity.

Read about Butamirate

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SINECOD Syrup Medicines Authority (MT) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R05DB13 Butamirate R Respiratory system → R05 Cough and cold preparations → R05D Cough suppressants, excl. combinations with expectorants → R05DB Other cough suppressants
Discover more medicines within R05DB13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-257908680, HR-H-699164552
Country: MT Medicines Authority Identifier(s): MA1177/00101
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100076052, 100076069, 100264865, 100292040, 100310000, 100437142
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W63408001
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8681291090110, 8681291090127, 8681291570094, 8681291570100

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.